Tag: Trust in pharma
Latest articles
NHS England makes Roche’s Hemlibra® available on NHS
NHS England has made Roche's Hemlibra® available on NHS. It is to fund the “life-changing treatment” for thousands of people with severe Haemophilia, which...
ABPI says prioritise ‘vaccine hesitancy’ as UK loses measles-free status
Responding to the news that the UK Prime Minister has committed to improving declining vaccination rates, Dr Sheuli Porkess, Executive Director at the ABPI,...
AbbVie receives FDA approval of RINVOQ™
The U.S. Food and Drug Administration (FDA) has approved AbbVie's RINVOQ™ (upadacitinib), a 15 mg, once-daily oral Janus kinase (JAK) inhibitor, for the treatment...
Popular articles
NHS England makes Roche’s Hemlibra® available on NHS
NHS England has made Roche's Hemlibra® available on NHS. It is to fund the “life-changing treatment” for thousands of people with severe Haemophilia, which...
Building trust in health with sales representatives
Paul Terry explores how the sales representative is best placed to build trust with the health sector, and how industry needs to adapt to...
Prevention Green Paper published – Advancing our health: prevention in the 2020s
The Cabinet Office and Department of Health and Social Care have published their Prevention Green Paper, Advancing our health: prevention in the 2020s. It...
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...
AbbVie receives FDA approval of RINVOQ™
The U.S. Food and Drug Administration (FDA) has approved AbbVie's RINVOQ™ (upadacitinib), a 15 mg, once-daily oral Janus kinase (JAK) inhibitor, for the treatment...